Thank you David, and good morning everybody. Thank you for joining the call. In the first quarter of 2018, Lightbridge reached the major goal of launching Enfission, our 50-50 joint venture with Framatome to complete the development, regulatory licensing, manufacturing and selling of nuclear fuel assemblies based on Lightbridge-designed metallic fuel technology and other advanced nuclear fuel intellectual property. As those of you who've been following our progress now, Framatome is the ideal partner as the global leader in the nuclear power industry, designing, servicing, fueling and advancing the global fleet of power reactors. Framatome brings large-scale manufacturing capabilities in the United States, an impeccable reputation as a nuclear fuel supplier and a large global footprint. Framatome is majority-owned by EDF, the largest nuclear reactor operator in the world. I'd like to take a moment to walk through key milestones we've accomplished in the short period since the launch of Enfission on January 25th and the timeline of key events going forward. First, we established a corporate governance and project management structure to ensure effective project control and oversight. Yesterday we announced the directors and officers of Enfission. Second, in terms of manufacturing, we completed and issued preliminary specifications and requests for quotation, RFQs, for scope on several fabrication-related tasks. We also completed a technical and commercial assessment for two suppliers and identified options to be evaluated for commercial-scale fabrication process optimization. Third, in terms of fuel design, we launched a critical heat flux test program. We also completed procedures for the first test rig qualification and interim inspection of equipment for irradiation testing. And fourth, in terms of regulatory licensing, we initiated preparation of our NRC regulatory licensing plan and identified identification of criteria for the standard review plan. As far as upcoming milestones, we have laid out a series of key milestones and a timeline of events we are working towards. First, we will begin by having semi-scale metallic fuel samples fabricated in 2019 to 2020 for irradiation testing under prototypic commercial reactor conditions. Again a benefit of the JV is that Framatome has extensive manufacturing capabilities and expertise that will enable Enfission to design the entire system to the exact specifications required. Second, upon completion of the fabrication and manufacturing, we plan to begin in-reactor and out-of-reactor experiments in 2020 to 2021. This will be another major milestone for the JV and we believe will drive massive value for shareholders, similar to a biotech completing its Phase III trials. Third, we plan to establish a pilot-scale fuel fabrication facility and demonstrate full-length fabrication of our metallic fuel rods, again as early as 2020. And fourth, we plan to begin lead test assembly operation in a full-size commercial light water reactor, which involves testing a limited number of full-scale fuel samplings in the core of a commercial nuclear power plant over three 18-month cycles as early as 2023 to 2024. At this point, our fuel will be on full display to the world and the nuclear power industry will be abundantly aware of the tremendous economic upside of our fuel as well as the safety and other benefits. In a few moments I'll also discuss new plans to start demonstration of our fuel in a commercial reactor in the United States in 2021. Earlier this month, an independent scientific paper was published in Nuclear Engineering and Design, a technical journal affiliated with the European Nuclear Society. This peer-reviewed paper reports the results of a study that shows that Lightbridge's spent fuel could not be used by would be proliferators to make nuclear bombs. The abstract states that the plutonium from Lightbridge's spent fuel would have the tremendous benefit of being useless for a nuclear explosive device. The paper in a leading nuclear energy journal is helping to drive further awareness and support of our fuel within both governmental and non-governmental organizations. I suspect this paper is a reason we're here at Fox today with issues around the Iran deal and issues relating to nuclear non-proliferation and about 40 minutes from now we'll see what they ask us on the air. The White House has also placed nuclear energy at the forefront of its energy agenda, including new programs to boost nuclear power research and development. We're seeing tremendous support from the administration. Along these lines I'd like to point out that for the first time in 23 years, the U.S. Department of Energy has resumed operations at the transient reactor test facility, also known as TREAT. This reactor is a crucial part of the nation's nuclear R&D infrastructure and provides the capability to test nuclear reactor fuels and materials under extreme conditions, accident conditions. Such testing can help to improve safety and performance of the current and future nuclear reactor fleet. We believe this is a major development and hold enormous promise for Lightbridge. I'll touch on the importance of this reactor further in a moment. We've been planning to be in irradiation of metallic fuel samples in the Halden research reactor in Norway in the 2020 to 2021 timeframe. The Halden reactor is operated by the Institute for Energy Technology, known as IFE from its Norwegian acronym. The current operating license of the Halden research reactor is valid through the end of 2020. On June 27th IFE's board of directors will decide whether to seek renewal of the Halden reactor operating license beyond 2020. On April 6th IFE issued a press release disclosing the discovery of a malfunctioning valve during a planned maintenance outage of the Halden reactor. The malfunctioning valve delayed the planned April 9, 2018, restart of the reactor. Based on recent communications with IFE, we believe it is likely that IFE's board will decide not to seek to renew the operating license of the Halden reactor, but we won't know for sure until the decision by the IFE board on June 27. In the event that IFE's board decides not to seek an operating license renewal for Halden, we have been evaluating alternatives for backup reactor facilities, including the Advanced Test Reactor at Idaho National Laboratory in the United States. Working with the U.S. Department of Energy and its national laboratories can allow us to conduct the tests right here in the United States which may come with additional benefits. An additional option we are exploring with a major U.S. nuclear utility is a lead test rod program in a large U.S. commercial nuclear power plant that could provide an alternative to Halden. Rather than simulating a commercial reactor environment at Halden, we believe we'll be able to demonstrate the Lightbridge fuel in an actual commercial reactor in the United States starting in 2021, more on that to come. That's all we have for this call on it though. We are also preparing to apply for a non-diluted DoE funding. While it's still early to say for certain, we believe the grants could be quite significant and could help offset some of the development and regulatory costs. We believe our fuel development program is well suited for these grants. We hope to provide more details on our progress in the near future. Other proposed nuclear fuels have been mentioned in the news and in industry publications. While other nuclear fuels in development known as accident-tolerant fuels may bring safety advantages to reactors. None can bring both the significant safety advantages and the major economic benefits of our fuel. Lightbridge fuel can also uniquely bring significant benefits on the backend of the fuel-cycle by reducing the amount of spent fuel or waste per unit of electricity generated and with the waste having the major positive attribute of being useless for any nuclear explosives purposes as independently validated in the recent peer-reviewed publication. Finally, Lightbridge fuel also has advantages for extending the licensed life of reactors, which we can discuss further during the Q&A if you wish. That said, we don't necessarily see these other fuel concepts as competitive. Some of these other fuel concepts can be combined with the Lightbridge fuel, further enhancing the safety benefits of each technology while maintaining all of the Lightbridge fuel benefits. So to wrap up, I'd like to highlight three key points. First, our nuclear fuel designs are attracting significant attention at both the commercial and governmental levels in that our technology has a potential to enhance reactor safety; to improve nuclear power plant's economics; to increase power output and/or longer fuel-cycles at the utility's choice; improve proliferation resistance of spent fuel so you can't make bombs around the world from this spent fuel; reduce the amount of waste and extend the operating lives of reactors. Second, we continue to strengthen our intellectual property portfolio and have received patents covering our metallic nuclear fuel rod design in the key markets around the world. And third, our balance sheet is stronger than at any time in our corporate history as Linda will go into in more detail in a minute. We now have approximately $22 million of cash on hand and that $22 million doesn't include the $5.2 million of cash that we recently contribute into the Enfission bank account, all of which will help to accelerate our fuel development and commercialization efforts and showing that cash in the Lightbridge and Enfission accounts along with contributions from Framatome helps bring about support from the DoE and their funding. We see a massive opportunity ahead with key milestones forthcoming that we believe will drive significant value for shareholders. Now I'll turn the call over to Lightbridge's Chief Financial Officer, Linda Zwobota to summarize the company's financial results for the quarter.